Inhibikase Therapeutics (IKT) Debt Ratio (2020 - 2025)
Inhibikase Therapeutics' (IKT) Debt Ratio was 0.00 for Q2 2025, down 97.5% from 0.02 a year earlier and down 46.2% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Debt Ratio (2020 - 2025) Analysis & Trends
Dating back to Q4 2020, Inhibikase Therapeutics' Debt Ratio record includes 17 quarters.
- By year, Debt Ratio came in at 0.01 in FY2023 (+76.9%), 0.01 in FY2022 (-0.2%), 0.01 in FY2021 (-72.8%) and 0.02 in FY2020.
- The Q2 2025 figure ranks as the lowest quarterly Debt Ratio in data going back to Q4 2020.
- Year over year, Debt Ratio has now declined in each of the last three quarters, with growth averaging 60.5% over the last eight quarters.
- The high point for year-over-year Debt Ratio in five years was Q3 2024 (growth of 298.1%); the low point was Q2 2025 (a decline of 97.5%).
- Per Business Quant data, the three quarters before Q2 2025 came in at 0.00 (Q1 2025), 0.00 (Q4 2024) and 0.03 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Inhibikase Therapeutics | 352.63 Mn | -232.84 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.00 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.10 |
| Dec 31, 2020 | 0.02 |
API Access
Inhibikase Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();